ScholarIQanswers from OpenAlex & ORCID
Robert W. Simms
ResearcherPublications, citations & collaboration network
Robert W. Simms is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Robert W. Simms have?
ScholarIQindexed works
Robert W. Simms has 169 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Robert W. Simms have?
ScholarIQcitation count
Robert W. Simms has 21,611 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Robert W. Simms?
ScholarIQh-index
Robert W. Simms has an h-index of 59 in OpenAlex.
What is the i10-index of Robert W. Simms?
ScholarIQi10-index
Robert W. Simms has an i10-index of 111 in OpenAlex.
What is the ORCID of Robert W. Simms?
ScholarIQorcid
The ORCID for Robert W. Simms is on the source record.
What is the OpenAlex record for Robert W. Simms?
ScholarIQopenalex
The OpenAlex for Robert W. Simms is on the source record.
What are the most-cited papers on Robert W. Simms?
ScholarIQmost cited works
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
Keith Sullivan, Ellen Goldmuntz, Lynette Keyes-Elstein, Peter A. McSweeney, Ashley Pinckney, Beverly Welch, Maureen D. Mayes, Richard A. Nash, Leslie J. Crofford, Barry Eggleston, Sharon Castina, Linda M. Griffith, Julia Goldstein, Dennis Wallace, Oana Craciunescu, Dinesh Khanna, Rodney J. Folz, Jonathan Goldin, E. William St. Clair, James R. Seibold, Kristine Phillips, Shin Mineishi, Robert W. Simms, Karen K. Ballen, Mark H. Wener, George E. Georges, Shelly Heimfeld, Chitra Hosing, Stephen J. Forman, Suzanne Kafaja, Richard M. Silver, Leroy Griffing, Jan Storek, Sharon LeClercq, Richard Brasington, Mary Ellen Csuka, Christopher Bredeson, Carolyn A. Keever-Taylor, Robyn T. Domsic, M. Bashar Kahaleh, Thomas A. Medsger, Daniel E. Furst
Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease
Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements, Michael D. Roth, Daniel E. Furst, Richard M. Silver, Jonathan Goldin, Edgar Arriola, Charlie Strange, Marcy B. Bolster, James R. Seibold, D. Riley, Vivien Hsu, John Varga, Dean E. Schraufnagel, Arthur C. Theodore, Robert W. Simms, Robert A. Wise, Fred Wigley, Barbara White, Virginia Steen, Charles A. Read, Maureen D. Mayes, Ed Parsley, Kamal K. Mubarak, M. Kari Connolly, Jeffrey A. Golden, Mitchell A. Olman, Barri J. Fessler, Naomi F. Rothfield, Mark L. Metersky, Dinesh Khanna, Ning Li, Gang Li
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
Lisa Rice, Cristina M. Padilla, Sarah McLaughlin, Allison L. Mathes, Jessica Ziemek, Salma Goummih, Sashidhar Nakerakanti, Michael York, Giuseppina Farina, Michael L. Whitfield, Robert Spiera, Romy Christmann, Jessica Gordon, Janice Weinberg, Robert W. Simms, Robert Lafyatis